69448-0015 HERCESSI - CanMED: NDC

Product NDC:

69448-0015

Brand Name:

HERCESSI

Generic Name:

Trastuzumab-strf

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/7.4mL

Packages:

Code: 69448-0015-05

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (69448-015-05) / 7.4 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Jan. 1, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox